PATENT CLAIM ANALYSIS

Application Number: 15956640
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "266000"]

Abstract:
Solid forms comprising 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the solid forms, methods of making the solid forms and methods of their uses are disclosed.

Claim (Index 75):
The method of  claim 66 , wherein the disease or disorder is myelodysplastic syndrome or myeloproliferative disease.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.38095
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14317912', '13417055', '15670600', '14975484', '12237638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8539338430919368
- 35 USC 102 Novelty (BERT): 0.6005815280633522
- Combined Prediction Score: 0.8285986115890783
- Mean Citation Score: 601.95565
- Max Citation Score: 700.9701
- Similarity Product: 418.24755921337015

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test